These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3602076)

  • 1. Biopharmaceutical studies of oral formulations containing propyphenazone.
    Shekerdjiiski R; Paskov V; Lambov N; Gencheva P; Rachev D; Titeva S; Minkov E
    Pharmazie; 1987 Mar; 42(3):184-6. PubMed ID: 3602076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative biopharmaceutical study of tegalide].
    Lopatina NB; Lebedeva MN
    Med Parazitol (Mosk); 2000; (1):27-9. PubMed ID: 10808715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Formulations and bioavailability of propyphenazone in lyophilized tablets].
    Gafiţanu E; Dumistrăcel I; Antochi S
    Rev Med Chir Soc Med Nat Iasi; 1991; 95(1-2):127-8. PubMed ID: 1823403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Availability of propylphenazone from suppositories. 2. Bioavailability].
    Hackenberger F; Gabrio T; Grune D; Bornschein M; Dietzsch B; Voigt R
    Pharmazie; 1986 Apr; 41(4):244-7. PubMed ID: 3725865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of adjuvants on the pharmaceutical and biological availability of chlorpromazine hydrochloride].
    Voigt R; Thomas G
    Pharmazie; 1983 Nov; 38(11):736-9. PubMed ID: 6669593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the development of oral preparations of the combination sulfamoxole/trimethoprim (CN 3123) (author's transl)].
    Dechow HJ; Dölcher D; Hübner G; Kim S; Lämmerhirt K; Pich CH; Schmidt-Böthelt E
    Arzneimittelforschung; 1976; 26(42):596-613. PubMed ID: 947320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative pharmacokinetic study for tablet and suppository formulations of a combination product of caffeine, ethaverine, propyphenazone, paracetamol and phenobarbital (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1981; 31(1):105-9. PubMed ID: 7194086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral lyophilizate--an alternative for products with low-soluble drugs.
    Gafiţeanu E; Drăgănoiu S; Cojocaru I
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):170-3. PubMed ID: 10756792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of an extemporaneous suspension of propafenone made from tablets.
    Olguín HJ; Pérez CF; Pérez JF; Mendiola BR; Portugal MC; Chávez JB
    Biopharm Drug Dispos; 2006 Jul; 27(5):241-5. PubMed ID: 16586461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals].
    Zak AF; Ermolova OB
    Antibiotiki; 1976 Feb; 21(2):151-5. PubMed ID: 1275466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.
    Eichelbaum M; Ochs HR; Roberts G; Somogyi A
    Arzneimittelforschung; 1982; 32(5):575-8. PubMed ID: 7201837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant influence on disintegration time and other characteristics of propyphenazone-metamizol tablets.
    Duric M; Jovanovic M; Duric Z
    Acta Pharm Hung; 1988 Jul; 58(4):153-7. PubMed ID: 3223285
    [No Abstract]   [Full Text] [Related]  

  • 16. The rabbit as an experimental model for biopharmaceutical studies following rectal administration of theophylline.
    Van Aerde P; Moerman E; Van Severen R; Braeckman P
    Pharmazie; 1984 Mar; 39(3):171-2. PubMed ID: 6728890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Availability of propylphenazocine from suppositories. 1. In vitro bioavailability].
    Bornschein M; Voigt R; Hoffmann K
    Pharmazie; 1985 Oct; 40(10):718-9. PubMed ID: 4080788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study, on healthy volunteers, of the bioavailability of 2 pharmaceutical formulations of oral cofosfolactamines. Trials between subjects].
    Di Nola F; Soranzo ML
    Minerva Med; 1983 Feb; 74(6):239-48. PubMed ID: 6828256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of pyrazolone derivatives from suppositories formulated with hydrophilic and hydrophobic bases.
    Bećirević M; Petricić V
    Pharmazie; 1986 May; 41(5):338-40. PubMed ID: 3737665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutical aspects of the design of steroidal dosage forms.
    Short MP; Rhodes CT
    Pharmazie; 1973 Aug; 28(8):509-13. PubMed ID: 4593892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.